1 research outputs found
Evaluating the QT-Liability of a Drug during its Development
- Author
- A Dennis
- A Olatunde
- AE Lacerda
- B Darpo
- B Darpo
- BA Wible
- BK Malhotra
- BN Singh
- C Antzelevitch
- C Antzelevitch
- C Funck-Brentano
- C Valenzuela
- CB Eap
- CE Garnett
- CL Lawrence
- Committee for Medicinal Products for Human Use.
- D Escande
- D Escande
- D Kubitza
- D Rampe
- D Thomas
- D Thomas
- DB Serra
- DR Abernethy
- E Ficker
- EH Locati
- EL Strevel
- European Medicines Evaluation Agency.
- F Charpentier
- F Ponti de
- G Curigliano
- GA Robertson
- GW Abbott
- H Takemasa
- HC Bazett
- Health Canada Ministry of Health, Health ProductsFood Branch.
- Health Canada Ministry of Health, Health ProductsFood Branch.
- International Conference on Harmonisation.
- International Conference on Harmonisation.
- International Conference on Harmonisation.
- J Cheng
- J Kang
- J Liu
- J Mitcheson
- J Morganroth
- J Morganroth
- J Morganroth
- J Zeng
- J-G Shin
- JD Davis
- JF Solus
- K Hartigan-Go
- K Hartigan-Go
- KA Milton
- L Wang
- L Wu
- Lilly pulls out of R-fluoxetine deal.
- LL Eckhardt
- LS Fridericia
- M Desai
- M Malik
- M Malik
- M Malik
- M Murdoch
- MC Sanguinetti
- MH Shah
- MJ Ackerman
- MM Hutmacher
- P Milberg
- PJ Kannankeril
- R Bayer
- RH Clayton
- RL Martin
- RR Fenichel
- RR Shah
- RR Shah
- RR Shah
- RR Shah
- RR Shah
- RR Shah
- RS Judson
- S Grisanti
- S Ozawa
- S Rajamani
- SG Priori
- T Eggeling
- US FoodDrug Administration.
- VR Volperian
- W Haverkamp
- ZJ Huang
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study